GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Truking Technology 300358.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

9.03

0.00%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥5.76bn

FY2016FY2025

Net income

CN¥254.7m

FY2016FY2025

Free cash flow

CN¥489.5m

FY2016FY2025

Shareholders' equity

CN¥5.55bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥5.76bnCN¥5.83bnCN¥6.85bnCN¥6.45bnCN¥5.26bnCN¥3.58bnCN¥3.14bnCN¥1.63bnCN¥1.28bnCN¥975.0m
Gross profitCN¥1.86bnCN¥1.36bnCN¥2.13bnCN¥2.30bnCN¥2.08bnCN¥1.21bnCN¥956.4mCN¥527.9mCN¥489.6mCN¥436.1m
Research and developmentCN¥484.8mCN¥627.6mCN¥587.8mCN¥539.2mCN¥465.8mCN¥266.5mCN¥217.6mCN¥188.6mCN¥138.0mCN¥76.5m
Operating incomeCN¥410.9m−CN¥561.3mCN¥327.0mCN¥606.5mCN¥646.3mCN¥236.1mCN¥81.0mCN¥43.3mCN¥128.6mCN¥120.8m
Net incomeCN¥254.7m−CN¥452.7mCN¥317.1mCN¥567.4mCN¥566.4mCN¥200.5mCN¥65.2mCN¥41.3mCN¥160.4mCN¥120.1m
Diluted earnings per share0.43-0.770.541.070.980.380.080.090.340.25

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥13.16bnCN¥13.31bnCN¥11.66bnCN¥11.05bnCN¥9.95bnCN¥6.91bnCN¥4.50bnCN¥4.16bnCN¥3.96bnCN¥2.88bn
Cash and short-term investments—CN¥1.85bnCN¥807.2mCN¥1.14bnCN¥1.62bnCN¥865.6mCN¥657.0mCN¥559.9mCN¥376.2mCN¥161.7m
Total liabilitiesCN¥7.59bnCN¥8.99bnCN¥6.90bnCN¥6.75bnCN¥6.27bnCN¥4.03bnCN¥2.08bnCN¥1.77bnCN¥1.64bnCN¥1.21bn
DebtCN¥385.1mCN¥2.21bnCN¥679.3mCN¥495.4mCN¥310.2mCN¥977.4mCN¥619.3mCN¥418.0mCN¥296.0mCN¥128.0m
Shareholders' equityCN¥5.55bnCN¥4.29bnCN¥4.72bnCN¥4.21bnCN¥3.59bnCN¥2.80bnCN¥2.38bnCN¥2.36bnCN¥2.32bnCN¥1.67bn
Shares outstanding588m590m585m530m579m530m774m437m469m490m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥778.9mCN¥122.3mCN¥204.5mCN¥24.8mCN¥1.60bnCN¥926.9mCN¥274.2mCN¥204.4mCN¥160.0m−CN¥29.9m
Capital spending−CN¥289.4m−CN¥703.5m−CN¥617.5m−CN¥835.1m−CN¥547.0m−CN¥329.3m−CN¥138.0m−CN¥129.0m−CN¥98.1m−CN¥153.7m
Free cash flowCN¥489.5m−CN¥581.2m−CN¥412.9m−CN¥810.3mCN¥1.05bnCN¥597.6mCN¥136.2mCN¥75.4mCN¥61.9m−CN¥183.7m
Dividends paid−CN¥49.6m−CN¥108.1m−CN¥89.1m−CN¥69.1m−CN¥28.3m−CN¥16.4m−CN¥8.7m−CN¥18.1m−CN¥55.7m−CN¥12.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.51bnCN¥1.11bnCN¥1.87bnCN¥1.48bnCN¥1.33bnCN¥1.08bnCN¥1.66bnCN¥1.34bn
Gross profitCN¥513.2mCN¥416.5mCN¥643.0mCN¥492.6mCN¥399.4mCN¥322.4mCN¥279.6mCN¥345.7m
Operating incomeCN¥154.3mCN¥80.4mCN¥255.4mCN¥93.4m−CN¥22.8m−CN¥24.6m−CN¥297.0m−CN¥133.1m
Net incomeCN¥77.5mCN¥67.8mCN¥170.2mCN¥96.8m−CN¥3.7m−CN¥8.6m−CN¥265.4m−CN¥104.6m
Diluted earnings per share0.130.120.290.16-0.01-0.01-0.45-0.18
Cash from operations———CN¥313.0m−CN¥17.0m−CN¥144.0m—CN¥19.0m
Capital spending−CN¥23.0m−CN¥47.0m−CN¥37.0m−CN¥90.0m−CN¥75.0m−CN¥87.0m−CN¥176.0m−CN¥178.0m
Free cash flow———CN¥223.0m−CN¥92.0m−CN¥231.0m—−CN¥159.0m
Total assetsCN¥12.60bnCN¥12.99bnCN¥13.16bnCN¥13.17bnCN¥13.01bnCN¥13.20bnCN¥13.31bnCN¥13.54bn
Cash and short-term investments———CN¥1.86bnCN¥1.55bnCN¥1.76bnCN¥1.85bnCN¥1.56bn
DebtCN¥368.4mCN¥355.1mCN¥385.1mCN¥1.88bnCN¥2.35bnCN¥2.38bnCN¥2.16bnCN¥2.12bn
Shareholders' equityCN¥5.58bnCN¥5.57bnCN¥5.55bnCN¥4.48bnCN¥4.41bnCN¥4.32bnCN¥4.29bnCN¥4.63bn

Financial ratios

Data as of 9 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin32.2%23.4%31.0%35.6%39.5%33.7%
Operating margin5.5%-8.8%5.0%9.3%12.6%7.7%
Net margin4.4%-7.8%4.6%8.8%10.8%5.6%
Return on equity4.6%-10.6%6.7%13.5%15.8%7.2%
Return on assets1.9%-3.4%2.7%5.1%5.7%2.9%
Free cash flow yield19.2%14.8%14.8%17.1%39.2%25.0%
Revenue growth-1.1%-14.9%6.3%22.5%47.1%13.9%
Earnings growth-156.3%-242.8%-44.1%0.2%182.5%207.6%
Current ratio1.25x1.12x1.10x1.15x1.17x1.16x
Debt to equity0.07x0.50x0.13x0.10x0.07x0.28x
Equity ratio42.2%32.2%40.5%38.1%36.1%40.6%
Interest coverage4.50x-8.33x9.58x28.03x23.05x6.05x
R&D as a share of sales8.4%10.8%8.6%8.4%8.9%7.5%
Buybacks as a share of market value0.5%-0.9%-10.4%8.5%-9.3%31.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-3.7%10.0%19.4%
Operating income-12.2%11.7%10.4%
Net income-23.4%4.9%5.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin27.8%30.7%32.4%33.0%
Operating margin-1.3%3.1%4.9%5.3%
Net margin-1.7%2.8%4.3%4.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings22.6-8.919.713.826.629.182.381.734.570.3
Price to sales1.00.70.91.22.91.61.72.14.38.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 26 Jun 2026.

FY2026FY2024FY2023FY2022FY2021FY2020FY2019FY2017
Paid in the year0.070.100.100.120.050.0350.0220.061
  • 2-for-1 split · 19 Mar 2015
  • 8-for-5 split · 21 May 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.